Literature DB >> 4288481

Studies in myasthenia gravis. Short-term massive corticotropin therapy.

K E Osserman, G Genkins.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4288481

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  9 in total

1.  Decrease in the carbamylcholine-induced chemotaxis of monocytes in myasthenia gravis.

Authors:  S Sipka; P Diószeghy; F Mechler; K Lukács; J Szelényi; G Szegedi
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

2.  Benefit from adrenocorticotrophin in myasthenia gravis.

Authors:  L A Liversedge; G M Yuill; I M Wilkinson; J A Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-04       Impact factor: 10.154

Review 3.  President's address. Myasthenia gravis.

Authors:  J W Turner
Journal:  Proc R Soc Med       Date:  1974-08

Review 4.  Adrenal steroid therapy in neurological disease. Part I.

Authors:  A A Eisen; J W Norris
Journal:  Can Med Assoc J       Date:  1969-01-04       Impact factor: 8.262

Review 5.  Immunopathology of acetylcholine receptors in myasthenia gravis.

Authors:  M E Seybold; J M Lindstrom
Journal:  Springer Semin Immunopathol       Date:  1982

6.  Controversies about the treatment of myasthenia gravis.

Authors:  L P Rowland
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-07       Impact factor: 10.154

7.  Treatment of myasthenia gravis with adrenocorticotropic hormone (ACTH): massive short-term and maintenance treatment.

Authors:  C A Cape; R A Utterback
Journal:  J Neurol Neurosurg Psychiatry       Date:  1969-08       Impact factor: 10.154

8.  Treatment of ocular myasthenia with corticotrophin.

Authors:  F B Gibberd; F Navab; C L Smith
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-02       Impact factor: 10.154

9.  Myasthenia gravis and the myasthenic syndrome.

Authors:  C Herrmann
Journal:  Calif Med       Date:  1970-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.